Organiser: Dr. Thomas Hartung (DE), Professor of Pharmacology and Toxicology, University of Konstanz, Germany & Johns Hopkins Bloomberg School of Public Health, Dept. of Environmental Health Sciences & Molecular Microbiology and Immunology. Co-organiser: Aidan Gilligan (IRL), Founder, CEO SciCom – Making Sense of Science & Euroscience.

Wednesday 27th July, 2016: 12h50 – 14h05

Session Abstract:

Independent clinical trials are fundamental to improving the results, safety and cost-effectiveness of our health care systems. Yet, the exorbitant costs and acceptance hurdles involved often limit their scope to new products i.e. they are profit-driven and industry-led. Money matters. Important clinical interventions, surgery, physiotherapy, rehabilitation, public health measures etc. are of less interest to commercial sponsors seeking the lucrative benefits of primarily drug and device authorisation. While investigator-driven studies now find some support in the US, EU and elsewhere, they just cannot match the resources available for commercial clinical trials.

Organised by Aidan Gilligan (IRL), Founder, CEO SciCom - Making Sense of Science; Member of the Governing Board of Euroscience. Co-organised by: Human Sciences Research Council (HSRC) of South Africa.

Wednesday 9th December, 2015: 11h00 – 12h30
Science Forum South Africa

Session Description

In theory, access to breakthroughs in health science is a global public good. In practice, your life expectancy and quality of life depends on where you live and what socio-economic standing you have. This session address a wide variety of complex issues, ranging from individual lifestyle choices to environmental exposure factors, as well as the affordability of medical and health-care facilities.

Organizer: Aidan Gilligan (IRL), SciCom – Making Sense of Science.   Co-Organised by Dr. Michel Kazatchkine (FR), UN Secretary General’s Ban-Ki Moon’s Special Envoy on HIV/AIDS in Eastern Europe and Central Asia; Former Executive Director of the Global Fund to Fight Aids, Tuberculosis & Malaria.

8:00 – 9:30 AM, Saturday Feb 13th, 2016
Marriot Wardman Park

Session Description

The ‘Brain Age’ is here. Massive investments in brain research and cognitive neuroscience are transforming understanding of the human mind. This session unites global teams racing to unlock the human brain and how individual cells and complex neural circuits interact in both time and space. It unveils first insights into how scientists are building “mini-brains” on a chip. The neurons of these 3-dimensional organoids communicate spontaneously by neurotransmitters and electrical depolarisation – they are thinking.

Organizer: Mr Daan du Toit (SA), Deputy Director-General, International Cooperation and Resources, Department of Science and Technology, Government of South Africa.  Co-Organised by Mr Satoru Ohtake (JP), Senior Executive Director, Japan Science & Technology Agency (JST).

1:00 - 2:30 PM, Saturday, February 13th 2016
Hoover (Marriott Wardman Park)

Session Description

Health diplomacy is the most active field of science diplomacy. This high-level talk maps the evolution of health from a restricted technical/medical area to today’s core role worldwide binding economic/trade/environment and human security/rights agendas. UN, African and Asian insights, amongst others, focus on how countries large and small, developed and developing, exercise health diplomacy through politics for the purpose of representation and cooperation, while improving systems and securing the right to science for vulnerable citizens. News of shared results and exciting new partnerships are given. Why health so dominates foreign affairs at regional, international and global levels is explained.